Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 57.58

+0.9%

Dec 10 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (14258)	11/20/2004 5:49:34 PM
From: former_pgs	Read Replies (2) of 52153

Thanks. I post at Yahoo because it appeals to the down and dirty, lowest common denominator side of my personality. It's no fun when everyone is nice and respectful... i need to roll around in the filth occasionally :-) As an aside, I read a recent post of yours that was a "Dear Dr. Goddard" letter. Out of curiosity, is this just public venting into empty space, or is there an expectation that some in biotech companies follow SI? From some of the management efforts I've seen in biotech, it would be adviseable. With regards to Dr. Goddard, he just waffled on his long-standing promise to become profitable within 18 months of Tarceva's launch. In the post-approval CC, the new timeline was announced to be 3 years. I don't believe that this is simply a reflection of the modest pricing for Tarceva. I think that they have some real issues with respect to cost control at the company. It would be nice to see that addressed, rather than having Goddard throw more equity (investor dilution) at the problem...

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next